Zdrowie i gospodarka · 26/08/2011
NIH to Grant Exclusive License for Anthrax Vaccine and Monoclonal Antibodies
The National Institutes of Health (NIH) is issuing a notice of its intention to grant an exclusive license to practice certain inventions related to anthrax vaccines and monoclonal antibodies, as outlined in three patent applications filed by researchers at NIH.